2024
Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines
Adin M, Isufi E, Wu J, Pang Y, Nguyen D, Has D, Caner C, Aboueldaha N, Mossa-Basha M, Pucar D. Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines. Nuclear Medicine Communications 2024, 45: 474-480. PMID: 38465449, DOI: 10.1097/mnm.0000000000001833.Peer-Reviewed Original ResearchAxillary lymph nodesWhole virus vaccineLymph nodesMRNA vaccinesNatural courseValue of clinical parametersCOVID-19 mRNA vaccinesPredictive value of clinical parametersDose of vaccine administrationPET-CT studiesCohort of oncology patientsDeauville criteriaPET criteriaClinical parametersYounger patientsSingle doseModerna recipientsJ&J vaccinePET-positiveMultivariate analysisVaccine typesOncology patientsPredictive valueVaccine administrationModerna vaccine
2022
Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
Adin ME, Wu J, Isufi E, Tsui E, Pucar D. Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer. Journal Of Breast Cancer 2022, 25: 140-144. PMID: 35380021, PMCID: PMC9065355, DOI: 10.4048/jbc.2022.25.e12.Peer-Reviewed Case Reports and Technical NotesLymph nodesNodal enlargementAxillary lymphadenopathyMRNA coronavirus disease 2019 (COVID-19) vaccinesBilateral axillary lymph nodesCOVID-19 vaccine recipientsRight-sided lymph nodesMRNA COVID-19 vaccinationCoronavirus disease 2019 (COVID-19) vaccinesIpsilateral axillary lymphadenopathyMalignant axillary lymphadenopathyAxillary lymph nodesPre-menopausal femalesRight breast lumpBreast cancer patientsCommon benign conditionReactive lymph nodesCOVID-19 vaccinationPotential disease progressionMagnetic resonance imagingVaccine recipientsSecond doseContralateral nodesCortical thickeningBreast lump